Literature DB >> 8473480

Preventing antiphospholipid antibody-induced fetal loss: a new idea.

M D Lockshin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8473480      PMCID： PMC288093          DOI： 10.1172/JCI116323

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  11 in total

1.  Antiphospholipid antibody/lupus anticoagulant workshop.

Authors:  M D Lockshin; C H Letendre
Journal:  Arthritis Rheum       Date:  1992-10

2.  Repeated fetal losses associated with antiphospholipid antibodies: a collaborative randomized trial comparing prednisone with low-dose heparin treatment.

Authors:  F S Cowchock; E A Reece; D Balaban; D W Branch; L Plouffe
Journal:  Am J Obstet Gynecol       Date:  1992-05       Impact factor: 8.661

3.  Control of fetal survival in CBA x DBA/2 mice by lymphokine therapy.

Authors:  G Chaouat; E Menu; D A Clark; M Dy; M Minkowski; T G Wegmann
Journal:  J Reprod Fertil       Date:  1990-07

4.  Induction of primary antiphospholipid syndrome in mice by immunization with a human monoclonal anticardiolipin antibody (H-3).

Authors:  R Bakimer; P Fishman; M Blank; B Sredni; M Djaldetti; Y Shoenfeld
Journal:  J Clin Invest       Date:  1992-05       Impact factor: 14.808

5.  Induction of antiphospholipid autoantibodies by immunization with beta 2 glycoprotein I (apolipoprotein H).

Authors:  A E Gharavi; L R Sammaritano; J Wen; K B Elkon
Journal:  J Clin Invest       Date:  1992-09       Impact factor: 14.808

6.  Histopathological findings in placentae from patients with intra-uterine fetal death and anti-phospholipid antibodies.

Authors:  H J Out; C D Kooijman; H W Bruinse; R H Derksen
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  1991-10-08       Impact factor: 2.435

7.  Phospholipid binding of antiphospholipid antibodies and placental anticoagulant protein.

Authors:  L R Sammaritano; A E Gharavi; C Soberano; R A Levy; M D Lockshin
Journal:  J Clin Immunol       Date:  1992-01       Impact factor: 8.317

8.  Prevention of fetal loss in experimental antiphospholipid syndrome by in vivo administration of recombinant interleukin-3.

Authors:  P Fishman; E Falach-Vaknine; R Zigelman; R Bakimer; B Sredni; M Djaldetti; Y Shoenfeld
Journal:  J Clin Invest       Date:  1993-04       Impact factor: 14.808

9.  The putative role of cytokines in the induction of primary anti-phospholipid syndrome in mice.

Authors:  P Fishman; R Bakimer; M Blank; D Sredni; M Djaldetti; Y Shoenfeld
Journal:  Clin Exp Immunol       Date:  1992-11       Impact factor: 4.330

10.  Effects of the lupus anticoagulant in patients with systemic lupus erythematosus on endothelial cell prostacyclin release and procoagulant activity.

Authors:  M H Rustin; H A Bull; S J Machin; D A Isenberg; M L Snaith; P M Dowd
Journal:  J Invest Dermatol       Date:  1988-05       Impact factor: 8.551
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.